NICE recommends new chemotherapy-free treatment option for untreated chronic lymphocytic leukaemia

Clinical trial evidence shows that CLL treated with venetoclax plus obinutuzumab takes longer to progress than with other treatment

Join OnMedica and benefit from:

  • Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
  • High-quality, evidence-based content developed by expert editors and clinicians
  • Articles, quizzes, videos, visual summaries and more
  • Regulatory alerts and round-up of medical journals
  • New content added daily, so you know you’re always up to date

Existing members Sign in